SCHEMBL3899524

SCHEMBL3899524

C=CCNC(=O)OC1CCC(CNC(=O)c2ccccc2OC)(c2ccccc2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3908371 1.00 KCNA3 (1.00) KCNA3
SCHEMBL3898079 0.94 KCNA3 (0.88) KCNA3
SCHEMBL3908635 0.92 KCNA3 (0.85) KCNA3
SCHEMBL3901643 0.91 KCNA3 (0.84) KCNA3
SCHEMBL3903211 0.91 KCNA3 (0.83) KCNA3
SCHEMBL3901594 0.90 KCNA3 (1.00) KCNA3
SCHEMBL3968487 0.90 KCNA3 (0.82) KCNA3
SCHEMBL7569017 0.90 KCNA3 (0.82) KCNA3
SCHEMBL3895291 0.88 KCNA3 (0.87) KCNA3
SCHEMBL3895286 0.88 KCNA3 (0.87) KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143965-B1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-02-25 EP claimed
EP-1368020-B1 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO INC (US) 2008-03-05 EP claimed
US-20040115739-A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells GARCIA MARIA L (US) 2004-06-17 US claimed
EP-1368020-A4 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO INC (US) 2004-05-12 EP claimed
EP-1368020-A2 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS Merck & Co., Inc. (US) 2003-12-10 EP claimed
US-6632836-B1 To treat autoimmune disorders, cardiac arrhythmias and the like MERCK & CO., INC. 2003-10-14 US claimed
WO-2002060340-A9 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO INC (US) 2002-11-21 WO claimed
EP-1143965-A4 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2002-10-09 EP claimed
WO-2002060340-A2 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO., INC. (US) 2002-08-08 WO claimed
EP-1143965-A1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2001-10-17 EP claimed
WO-2000025770-A1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2000-05-11 WO claimed
EP-1143965-B1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-02-25 EP disclosed
EP-1368020-B1 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO INC (US) 2008-03-05 EP disclosed
US-20040115739-A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells GARCIA MARIA L (US) 2004-06-17 US disclosed
EP-1368020-A4 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO INC (US) 2004-05-12 EP disclosed
WO-2002060340-A9 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO INC (US) 2002-11-21 WO disclosed
EP-1143965-A4 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2002-10-09 EP disclosed
WO-2002060340-A2 METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS MERCK & CO., INC. (US) 2002-08-08 WO disclosed
EP-1143965-A1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2001-10-17 EP disclosed
WO-2000025770-A1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2000-05-11 WO disclosed